Pfizer, BioNTech to supply 120 mln doses of coronavirus vaccine to Japan
The companies said, assuming success of the vaccine in clinical studies, they are on track to seek regulatory review for the vaccine as early as October
Takenobu Tonegawa, 41, who owns a video production firm, cycles as he works his part-time job as Uber Eats delivery person amid the coronavirus disease (Covid-19) outbreak, in Tokyo, Japan July 16, 2020. Picture taken July 16, 2020. Photo:Reuters
Pfizer Inc and BioNTech SE have agreed to supply Japan with 120 million doses of their mRNA-based vaccine candidate against the novel coronavirus in the first half of 2021, the companies said on Friday.
The companies said, assuming success of the vaccine in clinical studies, they are on track to seek regulatory review for the vaccine as early as October.
The companies did not disclose the financial details of the agreement.
Keep updated, follow The Business Standard's Google news channel
